Erregistratu | Sartu

Ients with advanced ovarian carcinoma? Am J Obstet Gynecol. 2014;211(3):231. e231?39. 3. Martin LP, Sill M, Shahin MS, Powell M, DiSilvestro P, Landrum LM, et al. A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2014;132(3):526?0. 4. Matsu

Nork bozkatu du Artikulu hau


Iruzkinak


Sartu komentatzeko edo erregistratu hemen.

Pligg is an open source content management system that lets you easily create your own social network.